KLIFO Gets Approval for New Clinical Trial Supply Facility in Copenhagen

KLIFO, a European provider of Clinical Trial Supply (CTS) packaging and distribution services, has received Manufacturing and Importation Authorization from the Danish Medicines Agency for its new 65,000-sq.-ft. Abildager facility in Copenhagen.

This authorization marks a significant milestone in KLIFO’s growth in the CTS solutions space for the pharmaceutical and biotech industries. With the new facility, KLIFO aims to accelerate project setup, reduce turnaround times, and minimize clinical supply chain issues.

The purpose-built facility is designed to meet the increasing demand for advanced clinical trial supply services and includes significantly expanded capacity to support small-scale studies through to global Phase III and post-marketing trials; comprehensive temperature  management  from  controlled  room temperature  to  -80°C for storage, primary and secondary packaging, and distribution; and low-light capabilities for light-sensitive products.

“Approval of our new facility represents a major step forward for KLIFO, and the site has already attracted significant interest from Nordic and international clients, reinforcing Copenhagen’s position as a leading life science hub in Europe,” said René Pedersen, CEO, KLIFO. “We can now offer even greater capacity to meet complex clinical trial supply chain needs globally while maintaining our focus on quality, compliance, and flexibility.”